ATE191006T1 - Menschliche monoklonale antikörper gegen rhesus d und zellinien die diese produzieren - Google Patents
Menschliche monoklonale antikörper gegen rhesus d und zellinien die diese produzierenInfo
- Publication number
- ATE191006T1 ATE191006T1 AT93201797T AT93201797T ATE191006T1 AT E191006 T1 ATE191006 T1 AT E191006T1 AT 93201797 T AT93201797 T AT 93201797T AT 93201797 T AT93201797 T AT 93201797T AT E191006 T1 ATE191006 T1 AT E191006T1
- Authority
- AT
- Austria
- Prior art keywords
- rhesus
- produce
- cell lines
- human monoclonal
- monoclonal antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9207893A FR2692786B1 (fr) | 1992-06-26 | 1992-06-26 | Anticorps monoclonaux humains anti-rhesus d et lignees cellulaires les produisant. |
DE19924224357 DE4224357C2 (de) | 1992-07-23 | 1992-07-23 | Arzneimittel zur Prophylaxe von HDN, enthaltend menschliche monoclonale anti-Rhesus (D)-Antikörper |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE191006T1 true ATE191006T1 (de) | 2000-04-15 |
Family
ID=25916870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93201797T ATE191006T1 (de) | 1992-06-26 | 1993-06-22 | Menschliche monoklonale antikörper gegen rhesus d und zellinien die diese produzieren |
Country Status (12)
Country | Link |
---|---|
US (1) | US5851524A (de) |
EP (1) | EP0576093B1 (de) |
AT (1) | ATE191006T1 (de) |
AU (1) | AU678364B2 (de) |
BR (1) | BR9305557A (de) |
CA (1) | CA2116246A1 (de) |
DE (1) | DE69328135D1 (de) |
FI (1) | FI940811A (de) |
HU (1) | HUT68624A (de) |
MX (1) | MX9303839A (de) |
PL (1) | PL302438A1 (de) |
WO (1) | WO1994000561A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2807767B1 (fr) | 2000-04-12 | 2005-01-14 | Lab Francais Du Fractionnement | Anticorps monoclonaux anti-d |
FR2858235B1 (fr) * | 2003-07-31 | 2006-02-17 | Lab Francais Du Fractionnement | Utilisation d'anticorps optimises en adcc pour traiter les patients faibles repondeurs |
FR2861078B1 (fr) * | 2003-10-16 | 2007-09-21 | Lab Francais Du Fractionnement | NOUVELLES IgG3 UTILES POUR STIMULER LA PHAGOCYTOSE |
DE602005016818D1 (de) | 2004-07-20 | 2009-11-05 | Symphogen As | Verfahren zur charakterisierung einer polyklonalen zellinie |
CA2574062A1 (en) | 2004-07-20 | 2006-01-26 | Symphogen A/S | Anti-rhesus d recombinant polyclonal antibody and methods of manufacture |
TWI391399B (zh) | 2005-05-25 | 2013-04-01 | Hoffmann La Roche | 測定溶離多肽之鹽濃度之方法 |
WO2008145351A1 (en) | 2007-06-01 | 2008-12-04 | F. Hoffmann-La Roche Ag | Immunoglobulin purification |
CA2639003A1 (en) * | 2008-08-20 | 2010-02-20 | Canadian Blood Services | Inhibition of fc.gamma.r-mediated phagocytosis with reduced immunoglobulin preparations |
BRPI0923541A2 (pt) | 2008-12-22 | 2016-01-26 | Hoffmann La Roche | purificação de imunoglobulina |
WO2011028961A2 (en) | 2009-09-04 | 2011-03-10 | Xoma Technology Ltd. | Anti-botulism antibody coformulations |
US20110059079A1 (en) * | 2009-09-04 | 2011-03-10 | Xoma Technology Ltd. | Antibody Coformulations |
CN106267405B (zh) * | 2016-07-01 | 2019-02-19 | 翁炳焕 | 母胎血型不合溶血病治疗仪 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH652145A5 (de) * | 1982-01-22 | 1985-10-31 | Sandoz Ag | Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen. |
GB8722018D0 (en) * | 1987-09-18 | 1987-10-28 | Central Blood Lab Authority | Human anti-rh(d)monoclonal antibodies |
GB8722020D0 (en) * | 1987-09-18 | 1987-10-28 | Central Blood Lab Authority | Human anti-rh(d)monoclonal antibodies |
GB8722019D0 (en) * | 1987-09-18 | 1987-10-28 | Central Blood Lab Authority | Human anti-rh(d)monoclonal antibodies |
GB8906129D0 (en) * | 1989-03-17 | 1989-05-04 | Central Blood Lab Authority | Pharmaceutical preparations |
-
1993
- 1993-06-22 EP EP93201797A patent/EP0576093B1/de not_active Expired - Lifetime
- 1993-06-22 HU HU9400862A patent/HUT68624A/hu unknown
- 1993-06-22 PL PL93302438A patent/PL302438A1/xx unknown
- 1993-06-22 AT AT93201797T patent/ATE191006T1/de not_active IP Right Cessation
- 1993-06-22 BR BR9305557A patent/BR9305557A/pt not_active Application Discontinuation
- 1993-06-22 AU AU44197/93A patent/AU678364B2/en not_active Ceased
- 1993-06-22 CA CA002116246A patent/CA2116246A1/en not_active Abandoned
- 1993-06-22 DE DE69328135T patent/DE69328135D1/de not_active Expired - Lifetime
- 1993-06-22 WO PCT/EP1993/001591 patent/WO1994000561A1/en active Application Filing
- 1993-06-25 MX MX9303839A patent/MX9303839A/es not_active Application Discontinuation
-
1994
- 1994-02-21 FI FI940811A patent/FI940811A/fi unknown
-
1997
- 1997-02-10 US US08/798,444 patent/US5851524A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0576093B1 (de) | 2000-03-22 |
DE69328135D1 (de) | 2000-04-27 |
BR9305557A (pt) | 1997-03-25 |
CA2116246A1 (en) | 1994-01-06 |
MX9303839A (es) | 1994-08-31 |
PL302438A1 (en) | 1994-07-25 |
AU4419793A (en) | 1994-01-24 |
HUT68624A (en) | 1995-07-28 |
FI940811A0 (fi) | 1994-02-21 |
US5851524A (en) | 1998-12-22 |
WO1994000561A1 (en) | 1994-01-06 |
AU678364B2 (en) | 1997-05-29 |
EP0576093A1 (de) | 1993-12-29 |
HU9400862D0 (en) | 1994-06-28 |
FI940811A (fi) | 1994-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL300433I2 (en) | Methods and compositions for the treatment of glomerulonephritis. | |
TR200002405T2 (tr) | İnsan CD40' a karşı antikorlar | |
DE69328135D1 (de) | Menschliche monoklonale Antikörper gegen Rhesus D und Zellinien die diese produzieren | |
DE122004000036I1 (de) | Therapeutische Verwendung von chimerischen und markierten Antik¦rper gegen menschlichen B Lymphozyt beschr{nkter Differenzierung antigen f}r die Behandlung von B-Zell-Lymphoma. | |
TW376320B (en) | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma | |
ATE348882T1 (de) | Humanisierte monoklonale integrin antikörper | |
MXPA05014152A (es) | Anticuerpos dirigidos a los mutantes de delecion de receptor de factor de crecimiento epidermico y sus usos. | |
HK1008819A1 (en) | Piperidine derivatives as neurokinin antagonists | |
DE69233029D1 (de) | Menschliche mesenchym-stammzellen aus dem mark und monoklonale antikörper spezifisch gegen diese zellen | |
CY1112447T1 (el) | Ανθρωπινα αντισωματα για την ιντερλευκινη (ιντεrleukin) 15 (il-15) | |
MX9709238A (es) | Formulaciones farmaceuticas y de dieta para la profilaxis y tratamiento de trastornos gastrointestinales. | |
AU7690596A (en) | Anti-CD6 monoclonal antibodies and their uses | |
ZA961364B (en) | 1-Aryl-2-acylamino-ethane compounds | |
HK1016017A1 (en) | Gonococcal anti-idiotypic antibodies and methods and compositions using them | |
DE69007799D1 (de) | Pharmazeutische antigen-antikörper-komplexe enthaltende zusammensetzungen und deren anwendungen. | |
EP0339163A3 (en) | Monoclonal antibodies specific for hiv and hybridomas for their production | |
BG102667A (en) | Diosgenine-containing composition | |
ATE173504T1 (de) | Granulozytenbindende antikörperkonstrukte, ihre herstellung und verwendung | |
CA2070182A1 (en) | Chimeric immunoglobulin for cd4 receptors | |
DE69333302D1 (de) | Mikroorganismen, ihre herstellung und verwendung | |
IT1254705B (it) | Anticorpi monoclonali specifici per il fattore neuronotrofico ciliare (cntf) umano ricombinante | |
DE69534740D1 (en) | Analoge des thymosin alpha 1 | |
GEP20043233B (en) | Composition Containing Blocking Monoclonal Antibody VLA-1 | |
AU6829396A (en) | Compositions and their uses | |
ES1024266U (es) | Cuna anatomica mejorada. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |